These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8807204

  • 21. Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Robbesom AA, von Blomberg-van der Flier BM, Herbrink P, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.
    Int J Cancer; 1996 Dec 11; 68(6):731-8. PubMed ID: 8980175
    [Abstract] [Full Text] [Related]

  • 22. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.
    J Med Virol; 2000 Apr 11; 60(4):403-10. PubMed ID: 10686023
    [Abstract] [Full Text] [Related]

  • 23. Seric and local antibodies against a synthetic peptide of HPV16.
    Dreyfus M, Baldauf JJ, Ritter J, Obert G.
    Eur J Obstet Gynecol Reprod Biol; 1995 Apr 11; 59(2):187-91. PubMed ID: 7657014
    [Abstract] [Full Text] [Related]

  • 24. Antibody responses to HPV16 virus-like particles in women with cervical intraepithelial neoplasia infected with a variant HPV16.
    Ellis JR, Etherington I, Galloway D, Luesley D, Young LS.
    Lancet; 1997 Apr 12; 349(9058):1069-70. PubMed ID: 9107250
    [No Abstract] [Full Text] [Related]

  • 25. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K, Christensen ND, Höpfl R, Wartusch B, Zeimet A, Larcher C, Ruth N, Bergant A, Pirschner G, Dierich MP.
    Gynakol Geburtshilfliche Rundsch; 1995 Apr 12; 35 Suppl 1():25-31. PubMed ID: 8672922
    [Abstract] [Full Text] [Related]

  • 26. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1997 Apr 12; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [Abstract] [Full Text] [Related]

  • 27. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
    Sun Y, Eluf-Neto J, Bosch FX, Muñoz N, Walboomers JM, Meijer CJ, Shah KV, Clayman B, Viscidi RP.
    Cancer Epidemiol Biomarkers Prev; 1999 Oct 12; 8(10):935-40. PubMed ID: 10548324
    [Abstract] [Full Text] [Related]

  • 28. Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study.
    Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC.
    Gynecol Oncol; 2005 Dec 12; 99(3 Suppl 1):S262-8. PubMed ID: 16229879
    [Abstract] [Full Text] [Related]

  • 29. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) cervical infections in women with normal and abnormal cytology.
    Szkaradkiewicz A, Wal M, Kuch A, Pieta P.
    Pol J Microbiol; 2004 Dec 12; 53(2):95-9. PubMed ID: 15478354
    [Abstract] [Full Text] [Related]

  • 30. Characterization of IgA response among women with incident HPV 16 infection.
    Onda T, Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA.
    Virology; 2003 Jul 20; 312(1):213-21. PubMed ID: 12890634
    [Abstract] [Full Text] [Related]

  • 31. Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females.
    Matsumoto K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T.
    Jpn J Cancer Res; 1997 Apr 20; 88(4):369-75. PubMed ID: 9197528
    [Abstract] [Full Text] [Related]

  • 32. Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.
    van Doornum G, Prins M, Andersson-Ellström A, Dillner J.
    Sex Transm Infect; 1998 Oct 20; 74(5):354-60. PubMed ID: 10195032
    [Abstract] [Full Text] [Related]

  • 33. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
    Tsukui T, Hildesheim A, Schiffman MH, Lucci J, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA.
    Cancer Res; 1996 Sep 01; 56(17):3967-74. PubMed ID: 8752165
    [Abstract] [Full Text] [Related]

  • 34. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.
    Tachezy R, Hamsíková E, Hájek T, Mikysková I, Smahel M, Van Ranst M, Kanka J, Havránková A, Rob L, Guttner V, Slavík V, Anton M, Kratochvíl B, Kotrsová L, Vonka V.
    J Med Virol; 1999 Aug 01; 58(4):378-86. PubMed ID: 10421405
    [Abstract] [Full Text] [Related]

  • 35. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
    Wideroff L, Schiffman M, Haderer P, Armstrong A, Greer CE, Manos MM, Burk RD, Scott DR, Sherman ME, Schiller JT, Hoover RN, Tarone RE, Kirnbauer R.
    J Infect Dis; 1999 Nov 01; 180(5):1424-8. PubMed ID: 10515799
    [Abstract] [Full Text] [Related]

  • 36. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
    Elfgren K, Bistoletti P, Dillner L, Walboomers JM, Meijer CJ, Dillner J.
    Am J Obstet Gynecol; 1996 Mar 01; 174(3):937-42. PubMed ID: 8633673
    [Abstract] [Full Text] [Related]

  • 37. Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.
    Studentsov YY, Ho GY, Marks MA, Bierman R, Burk RD.
    J Clin Microbiol; 2003 Jul 01; 41(7):2827-34. PubMed ID: 12843008
    [Abstract] [Full Text] [Related]

  • 38. Occurrence of the antibody against human papillomavirus type 16 virion protein L2 in patients with cervical cancer and dysplasia.
    Kanda T, Teshima H, Katase K, Umezawa S, Watabe H, Takahashi H, Onda T, Yoshiike K.
    Intervirology; 1995 Jul 01; 38(3-4):187-91. PubMed ID: 8682615
    [Abstract] [Full Text] [Related]

  • 39. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
    Shah KV, Viscidi RP, Alberg AJ, Helzlsouer KJ, Comstock GW.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr 01; 6(4):233-7. PubMed ID: 9107427
    [Abstract] [Full Text] [Related]

  • 40. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF, Duk JM, Groenier KH, Burger MP, de Bruijn HW, Hollema H, Stolz E, Herbrink P.
    Cancer Immunol Immunother; 1997 Jun 01; 44(4):211-5. PubMed ID: 9222279
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.